期刊文献+

三阴性乳腺癌和非三阴性乳腺癌临床特征及预后的比较分析 被引量:4

下载PDF
导出
摘要 探讨三阴性和非三阴性乳腺癌临床特征及术后不同时间局部复发率、远处转移率及5年生存率。采用回顾性分析,收集两组病例资料进行分析,观察三阴组乳腺癌特点。三阴性乳腺癌发病以≤50岁、绝经前、TNM分期Ⅲ期、淋巴结转移及浸润性导管癌发病率明显增高(P<0.05);不同时间局部复发率及远处转移率均高于非三阴组(P<0.05);5年生存率明显降低(P<0.05)。三阴性乳腺癌发病特点为年龄小、绝经前、淋巴结转移率高,术后局部复发、远端转移率高,与肿瘤直径无关。预后争议明显,可能存在其它亚型。
出处 《现代诊断与治疗》 CAS 2014年第15期3529-3530,共2页 Modern Diagnosis and Treatment
  • 相关文献

参考文献5

二级参考文献59

  • 1Bauer KR, Brown M, Cress RD, et al. Descriptive analysis of es- trogen receptor (ER) - negative, progesterone receptor ( PR ) - negative, and Her2 -negative invasive breast cancer, the so- called triple - negative phenotype : a population - based study from the California Cancer Registry [ J]. Cancer, 2007, 109:1721 - 1728.
  • 2Foulkes W, Smith I, Reis - Filho JS. Triple - negative breast cancer[ J]. N Engl J Med, 2010, 363:1938 -1948.
  • 3Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer sub- types, and survival in the Carolina Breast Cancer Study [ J ]. JA- MA, 2006, 295:2492 -2502.
  • 4Cheang MC, Voduc D, Bajdik C, et al. Basal - like breast cancer defined by five biomarkers has superior prognostic value than triple -negative phenotype[J]. Clin Cancer Res, 2008, 14:1368 - 1376.
  • 5Dent R, Trudeau M, Pritchard KI, et al. Triple - negative breast cancer: clinical features and patterns of recurrence[ J ]. Clin Canc- er Res, 2007, 13:4429 -4434.
  • 6Voduc KD, Cheang MC, Tyldesley S, et al. Breast cancer sub- types and the risk of local and regional relapse[J].J Clin Oncol, 2010, 28 : 1684 - 1691.
  • 7Dent R, Hanna WM, Trudeau M, et al. Pattern of metastatic spread in triple - negative breast cancer [ J ]. Breast Cancer Res Treat,2009, 115:423 -428.
  • 8Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long - term survival in patients with triple - negative breast cancer[ J]. J Clin Oncol, 2008,26:1275 -1281.
  • 9Roche H, Fumoleau P, Spielmann M, et al. Sequential adjuvant epirubicin - based and doeetaxel chemotherapy for node - positive breast cancer patients: the FNCLCC PACS 01 Trial[J]. J Clin Oncol, 2006, 24:5664-5671.
  • 10O Shaughnessy J, Osborne C, Pippen JE, et al. Iniparib plus chemotherapy in metastatic triple- negative breast cancer[ J]. N Engl J Med, 2011, 364:205 -214.

共引文献104

同被引文献33

  • 1须捷平,徐曙光,张云,俞羚,吴连明,殷志强,曹晖.三阴性乳腺癌的临床病理特征和预后影响因素分析[J].上海交通大学学报(医学版),2011,31(5):637-641. 被引量:18
  • 2周纯武,李二妮.乳腺影像学发展历程及展望[J].中华放射学杂志,2013,47增刊:27-29.
  • 3Goldhirseh A, Wood WC, Coates AS, et al. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St.Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J]. Ann Oncol,2011,22(8) :1736--1747.
  • 4Morrow M. Personalizing extent of breast cancer surgery according to molecular subtypes [J]. Breast, 2013, 22 (Suppl 2) ..$106-- 109.
  • 5Matsunuma R, Oguchi M,Fujikane T, et al. Influence of lymphatic invasion on locoregional recurrence following mastectomy: Indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes[ J]. Int J Radiat Oncol Biol Phys,2012,83 (3) :845 -852.
  • 6Baam JE, Blciker EMA, Riel EV, et al. Active approach for breast cancer genetic counseling during radiotherapy: long-term psychoso- cial and medical impact [ J ]. Clinical Genetics, 2014,85 ( 6 ) : 524.
  • 7Cuzick J, Sestak I, Cawthorn S, et al. Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial [ J ]. Lancet Oncology, 2015,16 ( 1 ) : 67 - 75.
  • 8Houssami N, Macaskill P, Marinovich ML, et al. The association of surgical margins and local recurrence in women with early-stage in- vasive breast cancer treated with breast-conserving therapy:a meta- analysis [ J ]. Ann Surical Onco1,2014,21 ( 3 ) :717 - 730.
  • 9连臻强,何洁华,王曦,唐军,杨名添.乳腺癌不同分子亚型的临床特点和生存分析[J].中华乳腺病杂志(电子版),2009,3(2):5-9. 被引量:45
  • 10林菁,彭华毅.黄癸素诱导小鼠黑色素瘤B16细胞凋亡的研究[J].中国药理学通报,2010,26(12):1630-1634. 被引量:22

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部